Loading...
Loading...
India's carvedilol imports from UNITED STATES total $74.1K across 135 shipments from 15 foreign suppliers. ENDO PHARMACEUTICALS SOLUTIONS INC leads with $25.3K in import value; the top 5 suppliers together control 71.1% of this origin. Leading Indian buyers include PAR FORMULATIONS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for carvedilol โ a diversified sourcing base with multiple active suppliers from UNITED STATES.

ENDO PHARMACEUTICALS SOLUTIONS INC is the leading Carvedilol supplier from UNITED STATES to India, with import value of $25.3K across 7 shipments. The top 5 suppliers โ ENDO PHARMACEUTICALS SOLUTIONS INC, AMNEAL PHARMACEUTICALS OF LLC, PHARMACEUTICAL BUYERS, INC, ENDO PHARMACEUTICALS SOLUTIONS INC., AMSTERDAM PHARMA APTEKA RX INC โ collectively account for 71.1% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ENDO PHARMACEUTICALS SOLUTIONS INC | $25.3K | 7 | 34.2% |
| 2 | AMNEAL PHARMACEUTICALS OF LLC | $10.2K | 68 | 13.8% |
| 3 | PHARMACEUTICAL BUYERS, INC | $6.5K | 3 | 8.8% |
| 4 | ENDO PHARMACEUTICALS SOLUTIONS INC. | $5.6K | 5 | 7.6% |
| 5 | AMSTERDAM PHARMA APTEKA RX INC | $4.9K | 5 | 6.6% |
| 6 | M/S.RAFF & HALL PHARMACY | $4.8K | 1 | 6.5% |
| 7 | SUN PHARMACEUTICAL INDUSTRIES INC. | $4.5K | 10 | 6.0% |
| 8 | RAFF & HALL PHARMACY | $3.0K | 2 | 4.0% |
| 9 | OHM LABORATORIES, INC (A SUN PHARMA COMPANY) | $2.5K | 4 | 3.4% |
| 10 | AGRACE PHARMA. | $2.5K | 4 | 3.4% |
| 11 | ESPEE BIOPHARMA & FINECHEM LLC | $2.0K | 1 | 2.7% |
| 12 | SUN PHARMACEUTICAL INDUSTRIES INC | $1.0K | 3 | 1.4% |
| 13 | M/S RAFF & HALL PHARMACY | $511 | 1 | 0.7% |
| 14 | OHM LABORATORIES INC A SUN PHARMA C | $166 | 7 | 0.2% |
| 15 | Actavis Laboratories UT Inc | $140 | 1 | 0.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PAR FORMULATIONS PRIVATE LIMITED | $31.0K | 12 | 41.8% |
| 2 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $10.2K | 68 | 13.8% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $8.2K | 24 | 11.0% |
| 4 | WATSON PHARMA PRIVATE LIMITED | $6.7K | 4 | 9.0% |
| 5 | VENSURE PHARMA TECHNOLOGIES PRIVATE LIMITED | $4.9K | 5 | 6.6% |
| 6 | HETERO LABS LIMITED | $4.8K | 1 | 6.5% |
| 7 | AUROBINDO PHARMA LTD | $4.6K | 8 | 6.1% |
| 8 | CLIANTHA RESEARCH LIMITED | $3.0K | 2 | 4.0% |
| 9 | RUBICON RESEARCH LIMITED | $511 | 1 | 0.7% |
| 10 | ZYDUS LIFESCIENCES LIMITED | $243 | 6 | 0.3% |
| 11 | GLENMARK PHARMACEUTICALS LIMITED | $41 | 4 | 0.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Carvedilol suppliers from UNITED STATES to India include ENDO PHARMACEUTICALS SOLUTIONS INC, AMNEAL PHARMACEUTICALS OF LLC, PHARMACEUTICAL BUYERS, INC. The leading supplier is ENDO PHARMACEUTICALS SOLUTIONS INC with import value of $25.3K USD across 7 shipments. India imported Carvedilol worth $74.1K USD from UNITED STATES in total across 135 shipments.
India imported Carvedilol worth $74.1K USD from UNITED STATES across 135 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Carvedilol sourced from UNITED STATES include PAR FORMULATIONS PRIVATE LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED. The largest buyer is PAR FORMULATIONS PRIVATE LIMITED with $31.0K in imports across 12 shipments.
The total value of Carvedilol imports from UNITED STATES to India is $74.1K USD, across 135 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
135 Verified Shipments
15 suppliers, 11 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists